ActivaQ S.A., a biotechnological company created in 2011, is initiating its first steps in last generation biotherapeutics for the veterinary industry, particularly in aquaculture. For such purpose, years of I+D have been performed in order to develop several platforms that may enable further entry in the animal production market with effective, safe and sustainable biological products.
Our main focus is to deliver an integrated offer of products and services that are able to assess fish behavior in terms of immune response and oxidative stress, and thereby condition gene expression, through a directed biotherapeutic offer, for salmonid disease control and protection.
In addition, ActivaQ maintains a food safety unit, with our Dioxin Detection Laboratory, and a Fish Genetics unit, with our Integrated Genetic Handling Program and genetic molecular analyses, amongst others.
Shrimp Imports: Weak Yen Reduces Purchasing Power Japan
In the first quarter of 2024, Vietnamese shrimp exports to Japan reached 103 million USD, down 2% over the same period. After increasing by 30% in January, shrimp exports to Japan decreased by 21% and...
Copyright 1995 - 2024 Seafood Media Group Ltd.| All Rights Reserved. DISCLAIMER